IE
CATX icon

Israel Englander’s Perspective Therapeutics CATX Stock Holding History

Israel Englander’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
4,911,855
+865,215
+21% +$3.27M 0.01% 1785
2026
Q1 		$16.9M Buy
4,046,640
+2,640,266
+188% +$11.2M 0.01% 1690
2025
Q4 		$3.87M Sell
1,406,374
-1,154,738
-45% -$3.29M ﹤0.01% 3294
2025
Q3 		$8.78M Sell
2,561,112
-32,487
-1% -$118K ﹤0.01% 2521
2025
Q2 		$8.92M Buy
2,593,599
+2,485,612
+2,302% +$6.56M ﹤0.01% 2380
2025
Q1 		$230K Sell
107,987
-1,187,356
-92% -$3.56M ﹤0.01% 5236
2024
Q4 		$4.13M Buy
+1,295,343
New +$10.6M ﹤0.01% 2996
2024
Q3 		– Sell
-246,558
Closed -$2.46M – 6123
2024
Q2 		$2.46M Sell
246,558
-332,915
-57% -$4.81M ﹤0.01% 3363
2024
Q1 		$6.9M Buy
+579,473
New +$4.94M ﹤0.01% 2538
2023
Q1 		– Sell
-1,371
Closed -$3K – 6402
2022
Q4 		$3K Sell
1,371
-825
-38% -$2.72K ﹤0.01% 6356
2022
Q3 		$5K Sell
2,196
-1,531
-41% -$5.24K ﹤0.01% 6807
2022
Q2 		$12K Sell
3,727
-86
-2% -$263 ﹤0.01% 6618
2022
Q1 		$14K Buy
3,813
+1,669
+78% +$6.09K ﹤0.01% 6689
2021
Q4 		$8K Buy
+2,144
New +$11.4K ﹤0.01% 6664
2019
Q4 		– Sell
-2,115
Closed -$6K – 4229
2019
Q3 		$6K Buy
+2,115
New +$7.66K ﹤0.01% 4102
2015
Q3 		– Sell
-1,250
Closed -$19K – 3463
2015
Q2 		$19K Buy
+1,250
New +$20.3K ﹤0.01% 3246
2015
Q1 		– Sell
-7,493
Closed -$109K – 3608
2014
Q4 		$109K Buy
+7,493
New +$119K ﹤0.01% 3758

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Israel Englander's CATX Position: Q2 2026 in Review

Israel Englander increased its Perspective Therapeutics (CATX) stake by 21% in Q2 2026, buying an estimated $3.27M and bringing the position to 4,911,855 shares worth $16.7M. The position accounts for 0.01% of the portfolio, ranked #1785.

Israel Englander first reported a position in CATX in Q4 2014 and has held it in 17 quarters since. The position peaked at $16.9M in Q1 2026. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Israel Englander held 4,911,855 shares of Perspective Therapeutics worth $16.7M as of Q2 2026.
  • Israel Englander bought 865,215 Perspective Therapeutics shares in Q2 2026, an estimated $3.27M.
  • Perspective Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1785 holding.
  • Israel Englander first reported a position in Perspective Therapeutics in Q4 2014 and has held it in 17 quarters since.
  • Israel Englander's Perspective Therapeutics position peaked at $16.9M in Q1 2026.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.